Assess a proposed study with a biological agent. Which risk-assessment approach is strongest?
A skip assessment for familiar materials
B choose controls based only on cost
C assign containment solely from the agent name
D consider the agent and the specific procedures, exposure routes, scale, and controls
Answer: D. consider the agent and the specific procedures, exposure routes, scale, and controls. WHO’s risk-based approach evaluates the specific work and informs suitable controls rather than relying on a label alone.
A hazard has severe potential consequences but a low estimated likelihood under current controls. What is the best interpretation?
A risk still requires evaluation of both likelihood and consequence, including residual uncertainty
B controls make reassessment unnecessary
C risk is zero because likelihood is low
D severity alone proves an incident will occur
Answer: A. risk still requires evaluation of both likelihood and consequence, including residual uncertainty. Risk assessment considers both the likelihood and consequences of harm and should consider residual risk.
A new procedure increases sample concentration and adds an aerosol-generating step. What should happen before implementation?
A review and update the risk assessment and controls
B reuse the old assessment without review
C remove PPE to improve handling
D change only the sample label
Answer: A. review and update the risk assessment and controls. Changes in procedures or material can alter exposure and should trigger review of controls.
In the hierarchy of risk controls, which measure is generally more reliable than relying only on PPE?
A voluntary self-reporting only
B a verbal warning after every task
C a reminder poster alone
D engineering containment such as a suitable biological safety cabinet
Answer: D. engineering containment such as a suitable biological safety cabinet. Engineering controls provide a physical barrier and are generally more reliable than relying only on individual behavior or PPE.
A biological safety cabinet has been moved to a new location. What should be checked before use?
A certification and performance after relocation
B the number of posters nearby
C whether all staff have the same gloves
D the sample accession number
Answer: A. certification and performance after relocation. Cabinet performance should be verified after relocation before it is used for containment work.
A lab compares two disinfectants for a spill. Which evidence should guide selection?
A the bottle color only
B the fragrance of the product
C which one was purchased first
D the agent or material, product efficacy, surface, contact time, and local procedure
Answer: D. the agent or material, product efficacy, surface, contact time, and local procedure. Effective disinfection depends on agent, surface, product instructions, and correct contact time.
A lab uses a biological safety cabinet for work with a volatile toxic chemical. What is the concern?
A PPE is never needed
B the chemical becomes nonvolatile in a cabinet
C the cabinet guarantees protection from every vapor
D a biological cabinet may not be designed to control chemical vapors safely
Answer: D. a biological cabinet may not be designed to control chemical vapors safely. Cabinet type matters; biological containment does not automatically provide chemical-vapor protection.
An environmental assessment finds a modified plant can cross with a compatible wild relative. Which risk pathway should be evaluated?
A the laboratory’s autoclave cycle
B gene flow and its possible ecological consequences
C only the plant’s height
D the sequence file format
Answer: B. gene flow and its possible ecological consequences. Gene flow to related populations may affect persistence or ecological outcomes and should be assessed.
A modified microbe is intended for contained use but could survive outside the facility. Which control strategy is relevant?
A rely on a warning sign alone
B assume the organism will die immediately
C combine appropriate physical containment with validated biological safeguards and monitoring
D remove inventory records
Answer: C. combine appropriate physical containment with validated biological safeguards and monitoring. Containment can include physical and biological measures selected for the specific risks.
A biosafety assessment identifies a control that reduces exposure but leaves some residual risk. What should the team do?
A evaluate whether residual risk is acceptable and add controls if needed
B ignore the remaining risk
C stop documenting controls
D declare zero risk automatically
Answer: A. evaluate whether residual risk is acceptable and add controls if needed. Risk management should evaluate residual risk after controls are applied.
An ethics committee asks whether participants understand a genomic study’s future data sharing. Which evidence is most useful?
A a signed form alone with no discussion
B a consent process that explains sharing in understandable language and checks comprehension
C a sequence alignment report
D a laboratory certificate
Answer: B. a consent process that explains sharing in understandable language and checks comprehension. Consent should support understanding, not merely collect a signature.
A research participant asks to withdraw but the sample has already contributed to aggregated results. What response is most appropriate?
A tell the participant they can never withdraw
B promise to erase every derived result regardless of feasibility
C explain the options and limits described in consent and policy, without promising impossible deletion
D publish the sample identifier
Answer: C. explain the options and limits described in consent and policy, without promising impossible deletion. Researchers should honor available choices while accurately explaining limits once data have been aggregated or shared.
A study stores genome data without direct identifiers but retains detailed metadata that could identify a person. What remains necessary?
A removal of all metadata regardless of research purpose
B privacy and re-identification risk controls
C no access controls because names are absent
D public release of the linkage key
Answer: B. privacy and re-identification risk controls. Genomic data can be re-identified through combinations of data, so safeguards remain important.
A participant’s genomic data may reveal information about biological relatives. Which issue should be addressed?
A whether the lab has an autoclave
B familial implications and privacy in consent and data governance
C only the participant’s blood type
D the sequence file’s font
Answer: B. familial implications and privacy in consent and data governance. Genomic data may reveal information about relatives, so consent and privacy planning should consider familial implications.
A study recruits from a disadvantaged population because access is easy, while benefits will only be available to wealthy groups. Which ethical concern is raised?
A unfair distribution of burdens and benefits
B proper anonymization
C sequence coverage
D sample contamination
Answer: A. unfair distribution of burdens and benefits. Justice requires fair selection and consideration of who bears risks and receives benefits.
A community contributes samples and local knowledge to a genomic project. Which practice supports ethical partnership?
A engage the community and discuss governance and fair sharing of benefits
B publish identifiable community data
C assume individual consent covers every community issue
D collect materials without communication
Answer: A. engage the community and discuss governance and fair sharing of benefits. Community engagement and fair governance can address collective interests beyond individual consent.
A study uses human genome data from an earlier project. What must be checked before reuse?
A only sequence length
B whether the first study was published
C original consent scope, ethics approval, privacy safeguards, and applicable rules
D whether the data are in FASTA format
Answer: C. original consent scope, ethics approval, privacy safeguards, and applicable rules. Secondary use must be compatible with consent and oversight, with safeguards for sensitive data.
A gene-editing study proposes a heritable change in embryos. What distinction is central to ethical analysis?
A germline edits can never affect descendants
B both changes affect only the treated tissue
C somatic editing always changes offspring
D germline changes may be passed to future generations, unlike targeted somatic changes
Answer: D. germline changes may be passed to future generations, unlike targeted somatic changes. Germline changes may be inherited, raising implications for future generations.
A researcher finds an unexpected health-related result in a participant’s genome. Which factor should guide disclosure?
A whether the participant’s name is known
B the consent plan, result validity, clinical relevance, and appropriate support
C whether the result is publishable
D the researcher’s curiosity alone
Answer: B. the consent plan, result validity, clinical relevance, and appropriate support. Incidental findings require a planned approach that considers validity, relevance, consent, and support.
A study team has no agreed policy for returning individual genetic results. What should happen before enrollment?
A leave decisions to whichever analyst is on duty
B promise every raw result will be returned immediately
C develop and communicate a clear return-of-results policy
D avoid mentioning results in consent
Answer: C. develop and communicate a clear return-of-results policy. Participants should be informed about whether and how individual findings may be returned.
A lab discovers that a researcher has fabricated a control result. What is the appropriate response?
A alter the dataset to match the hypothesis
B delete the notebook
C preserve records and report through the institution’s research-integrity process
D wait until publication
Answer: C. preserve records and report through the institution’s research-integrity process. Fabrication is research misconduct and should be handled transparently through established institutional procedures.
Two collaborators disagree on authorship after the work is complete. Which practice would have helped most?
A list everyone who visited the lab
B agree on contributions and authorship criteria early and document changes
C omit the methods section
D assign authorship by seniority alone
Answer: B. agree on contributions and authorship criteria early and document changes. Transparent contribution criteria and early discussion reduce authorship disputes.
A project has a potential dual-use concern but also a legitimate public-health goal. What is the balanced response?
A cancel all beneficial research automatically
B ignore the concern because intent is good
C assess benefits and misuse risks, then apply proportionate safeguards and oversight
D publish all details without review
Answer: C. assess benefits and misuse risks, then apply proportionate safeguards and oversight. Risk-based oversight can support beneficial research while reducing misuse potential.
A laboratory biosecurity plan protects sensitive materials and records. Which measure is relevant?
A unlabeled storage
B open access for any visitor
C shared passwords
D controlled access, inventory accountability, and secure data handling
Answer: D. controlled access, inventory accountability, and secure data handling. Biosecurity controls can include access management, inventory, and protection of sensitive information.
A risk assessment identifies a spill route through a centrifuge. Which change best addresses the source of exposure?
A remove the incident log
B ask staff to work faster
C add a poster but keep the same setup
D use suitable containment and equipment controls for the procedure
Answer: D. use suitable containment and equipment controls for the procedure. Engineering and procedural controls should address the identified exposure pathway.